+8.08% for Injective — daily volatility and buying pressure spark cautious optimism

Traders Union
All News
Crypto News
Injective surges 8.08% to $4.95 today

Highlights

INJ trades at $4.95, above its MA-20 ($4.67) but below MA-50 ($5.38) and MA-200 ($10.22), indicating persistent medium- and long-term bearish trends.
Despite an 8.08% daily gain and intraday buyer strength, technicals such as MACD and ADX remain bearish with RSI neutral at 49.71 and Stoch RSI overbought.
INJ's expected weekly range is $4.75–$5.20, with less than 20% probability of a price increase as all weekly indicators maintain a bearish outlook.

Bearish technical signals diverge from intraday buyer dominance and volatility

Momentum on the daily timeframe is mixed: the MACD signals a strong sell and the ADX suggests a seller-dominated trend, but the Bull/Bear Power indicator shows strong buyer dominance intraday. RSI is neutral at 49.71, while the Stoch RSI flags overbought conditions, and the CCI reads neutral. The Awesome Oscillator is flat, failing to confirm a clear trend, and daily performance reveals an 8.08% gain ($0.37 higher) with a slight gap up from the previous close, as the price is trading near today’s high ($4.99) indicating strength toward the upper end of the range; intraday volatility has been moderate to high, with buyers maintaining upward pressure after the open. The divergence between bearish momentum signals and intraday buyer strength warrants caution.

Downside bias persists as weekly indicators point to bearish continuation

For the coming week, the expected trading range for INJ is $4.75 to $5.20, keeping price action within a ±5% volatility band relative to current levels and reflecting typical weekly volatility. Given all weekly indicators (RSI, ADX, MACD, MA-50) remain bearish, the probability of a price increase is very low (less than 20%), making a further decrease far more likely. Baseline scenario: INJ consolidates sideways within $4.75 – $5.20 as mixed signals play out; bullish scenario: a clear break above resistance at $5.38 could open up room for short covering and further gains; bearish scenario: a drop below $4.75 would expose the token to renewed selling toward next support levels.

Viktoras Karapetjanc, Senior Analyst at Traders Union, sees Injective holding ground despite prevailing bearish signals from major trend indicators. He notes intraday buyers are showing resilience, yet the broader risk profile remains skewed to the downside. In the absence of key news flow, sentiment will largely hinge on overall market direction and volatility. The analyst remains attentive to the $5.38 resistance as a potential pivot for renewed optimism. "While the probability of a short-term breakout is low, staying above $4.75 keeps buyer hope alive for now — I see this phase as primed for patient tactical positioning."

Last time, analysts noted that Injective is trading below key moving averages amid short- to long-term bearish momentum, with negative signals from MACD and a subdued RSI, even as intraday price action has shown some strength near resistance levels. Immediate support is near recent lows, with resistance at the Ichimoku Kijun, and the asset is expected to consolidate sideways within a defined range given prevailing conflicting momentum indicators.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.